BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Modak AS. 13 C breath tests in personalized medicine: fiction or reality? Expert Review of Molecular Diagnostics 2014;9:805-15. [DOI: 10.1586/erm.09.58] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Stockmann M, Lock JF. How far is the development of 13C-liver-function breath tests? Dig Dis Sci 2013;58:1804-5. [PMID: 23564300 DOI: 10.1007/s10620-013-2604-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Opdam FL, Gelderblom H, Guchelaar H. Phenotyping drug disposition in oncology. Cancer Treatment Reviews 2012;38:715-25. [DOI: 10.1016/j.ctrv.2011.12.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
3 Modak AS. Breath biomarkers for personalized medicine. Personalized Medicine 2010;7:643-53. [DOI: 10.2217/pme.10.61] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
4 De Kesel PMM, Lambert WE, Stove CP. Alternative Sampling Strategies for Cytochrome P450 Phenotyping. Clin Pharmacokinet 2016;55:169-84. [DOI: 10.1007/s40262-015-0306-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
5 Modak AS. Barriers to overcome for transition of breath tests from research to routine clinical practice. J Breath Res 2011;5:030202. [DOI: 10.1088/1752-7155/5/3/030202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
6 Modak AS. An Update on 13C-Breath Tests: The Transition to Acceptability into Clinical Practice. Volatile Biomarkers. Elsevier; 2013. pp. 244-62. [DOI: 10.1016/b978-0-44-462613-4.00014-3] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]